NHO Amicus Stem Cell Separator System Consumables
This federal contract opportunity has been awarded to on September 18, 2026.
Award Information
This solicitation resulted in an award to for approximately $55,745 on September 18, 2026. Similar contracts are typically issued by DEPT OF DEFENSE under 325413 (In-Vitro Diagnostic Substance Manufacturing).
Award details updated on September 19, 2026 following modification notice.
- Award Number
- HT941026PE174
- Award Amount
- $55,745
- Award Date
- September 18, 2026
Key Takeaways
- No response deadline specified - contact the agency for details
- Set-aside for No Set Aside businesses
- Work to be performed in CAMP PENDLETON, CA
- Industry: In-Vitro Diagnostic Substance Manufacturing
Contract Details
- Notice ID
- HT941026N0107
- Opportunity Type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE HEALTH AGENCY (DHA)
- Office
- DEFENSE HEALTH AGENCY HCD WEST
- Posted Date
- Friday, September 18, 2026
- Response Deadline
- Not specified
- PSC Code
- 6515
- Set-Aside
- No Set Aside
- Place of Performance
- CAMP PENDLETON, CA, 92055
- Status
- Active
Description
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division West (HCD-W), awarded a firm-fixed-price purchase order for Drop Shipment of FDA Fenwal Amicus Apheresis Reagents (Manufacturer: Fenwal, Inc.). This procurement supports the operational requirements of Naval Hospital Okinawa, Japan, and was conducted in accordance with RFO 12.102(a).
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in CAMP PENDLETON, CA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
